China Pioneer Pharma Holdings Limited, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China. It has a portfolio of pharmaceutical products, such as ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas, as well as medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company sells its products to hospitals and medical institutions, and pharmacies. It also sells ancillary tools and leases accessories; and sells dental devices. In addition, the company engages in the sale of imported in-licensed prescription products. China Pioneer Pharma Holdings Limited was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. China Pioneer Pharma Holdings Limited is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.
China Pioneer Pharma Dividend Announcement
• China Pioneer Pharma announced a semi annually dividend of HK$0.05 per ordinary share which will be made payable on 2024-11-15. Ex dividend date: 2024-10-30
• China Pioneer Pharma annual dividend for 2024 was HK$0.07
• China Pioneer Pharma annual dividend for 2023 was HK$0.07
• China Pioneer Pharma's trailing twelve-month (TTM) dividend yield is 3.69%
• China Pioneer Pharma's payout ratio for the trailing twelve months (TTM) is 53.19%
China Pioneer Pharma Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-10-30 | HK$0.05 | semi annually | 2024-11-15 |
2024-05-28 | HK$0.02 | semi annually | 2024-06-19 |
2023-10-04 | HK$0.02 | semi annually | 2023-10-20 |
2023-05-23 | HK$0.05 | semi annually | 2023-06-15 |
2022-10-05 | HK$0.02 | semi annually | 2022-10-20 |
2022-05-23 | HK$0.06 | semi annually | 2022-06-10 |
2021-09-29 | HK$0.06 | semi annually | 2021-10-15 |
2021-05-20 | HK$0.07 | semi annually | 2021-06-01 |
2020-09-23 | HK$0.07 | semi annually | 2020-10-20 |
2020-09-11 | HK$0.03 | semi annually | 2020-10-09 |
2020-06-11 | HK$0.03 | semi annually | |
2020-02-13 | HK$0.10 | semi annually | 2020-03-31 |
2017-10-16 | HK$0.06 | semi annually | 2017-10-30 |
2017-05-04 | HK$0.10 | semi annually | 2017-05-15 |
2016-09-21 | HK$0.07 | semi annually | 2016-10-14 |
2016-05-24 | HK$0.04 | semi annually | 2016-06-02 |
2015-09-15 | HK$0.06 | semi annually | 2015-10-14 |
2015-05-12 | HK$0.09 | semi annually | 2015-05-21 |
2014-09-10 | HK$0.09 | semi annually | 2014-09-23 |
2014-05-13 | HK$0.11 | semi annually | 2014-05-23 |
China Pioneer Pharma Dividend per year
China Pioneer Pharma Dividend growth
China Pioneer Pharma Dividend Yield
China Pioneer Pharma current trailing twelve-month (TTM) dividend yield is 3.69%. Interested in purchasing China Pioneer Pharma stock? Use our calculator to estimate your expected dividend yield:
China Pioneer Pharma Financial Ratios
China Pioneer Pharma Dividend FAQ
Other factors to consider when evaluating China Pioneer Pharma as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy China Pioneer Pharma stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: China Pioneer Pharma's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, China Pioneer Pharma publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, China Pioneer Pharma distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from China Pioneer Pharma are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: China Pioneer Pharma sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, China Pioneer Pharma distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: China Pioneer Pharma declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of China Pioneer Pharma's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review China Pioneer Pharma's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.